Latest / PETRI DISH PERSPECTIVES
Episode 78: Dr. Kristin Gleitsman on Using AI to Make Better Drug Development Decisions
Send us Fan Mail
After years of building discovery engines inside diagnostics, Kristin Gleitsman has become one of the more skeptical voices in AI and biology. A Caltech chemistry PhD, Kristin built Veracyte’s Discovery Research function from the ground up and helped shape the strategy behind its acquisition of C2i Genomics. Now, as Chief Science Officer of Eigen Bio, the focus is on a harder question than building bigger models: what has an AI model actually earned the right to claim?
In this episode, Kristin unpacks why more data layers don’t automatically mean more biological truth, how…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.